McElroy, Susan L.
Guerdjikova, Anna I.
Mori, Nicole
Romo-Nava, Francisco
Article History
First Online: 6 December 2018
Compliance with Ethical Standards
:
: No sources of funding were used to conduct this study or prepare this manuscript.
: SLM is a consultant to or member of the scientific advisory boards of Allergan, Avanir, Bracket, F. Hoffmann-La Roche Ltd., Mitsubishi Tanabe Pharma America, Myriad, Opiant, Shire, and Sunovion. She is a principal or co-investigator on studies sponsored by the Allergan, Avanir, Brainsway, the Marriott Foundation, Myriad, Neurocrine, Novo Nordisk, Shire, and Sunovion. She is also an inventor on US patent no. 6,323,236 B2, Use of Sulfamate Derivatives for Treating Impulse Control Disorders, and—along with the patent’s assignee—University of Cincinnati, Cincinnati, Ohio, has received payments from Johnson & Johnson in the past, which has exclusive rights under the patent. AIG, NM, and FR-N have no conflicts of interest that are directly relevant to the content of this article.
: All procedures performed in studies involving human participants, to the best of our knowledge, were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.